Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
AIN | US
-1.17
-2.07%
Consumer Cyclical
Textile Manufacturing
30/06/2024
24/04/2026
55.32
56.31
56.71
55.28
Albany International Corp. together with its subsidiaries engages in the textile and materials processing business. The company operates in two segments Machine Clothing (MC) and Albany Engineered Composites (AEC). The MC segment designs manufactures and markets paper machine clothing for use in the manufacturing of papers paperboards tissues towels nonwovens building products tannery and textiles. This segment offers forming pressing and drying fabrics as well as process belts; and engineered fabrics. The AEC segment 3D-woven and injected composite components for aircraft engines composite airframe and engine components for military and commercial aircraft. It operates in the United States Switzerland Brazil China France Mexico Italy and internationally. The company was incorporated in 1895 and is headquartered in Rochester New Hampshire.
View LessValue Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
Price Below SMA10D
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
35.1%1 month
38.5%3 months
35.6%6 months
38.4%21.29
-
2.43
0.39
0.22
9.81
2.09
2.00
265.62M
1.73B
1.73B
1.38
13.51
-7.30
21.10
11.62
1.81
1.28
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
4.02
Range1M
8.85
Range3M
12.05
Rel. volume
0.72
Price X volume
7.30M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
No data | |||||||
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Assertio Therapeutics Inc | ASRT | Drug Manufacturers-Specialty & Generic | 18.04 | 1.72B | 0.11% | n/a | 30.76% |
| Perrigo Company plc | PRGO | Drug Manufacturers-Specialty & Generic | 11.82 | 1.61B | 1.11% | n/a | 93.52% |
| Harrow Health Inc | HROW | Drug Manufacturers-Specialty & Generic | 39.7 | 1.41B | 2.45% | n/a | 331.16% |
| Clover Leaf Financial Corp | CLOV | Healthcare Plans | 2.43 | 1.21B | 1.25% | n/a | 1.23% |
| Pacira Pharmaceuticals Inc | PCRX | Drug Manufacturers-Specialty & Generic | 24.51 | 1.13B | -3.35% | 13.05 | 73.76% |
| Karyopharm Therapeutics Inc | KPTI | Drug Manufacturers-Specialty & Generic | 8.66 | 1.08B | -1.03% | n/a | -148.05% |
| Amphastar Pharmaceuticals Inc | AMPH | Drug Manufacturers-Specialty & Generic | 21.41 | 1.05B | 1.90% | 16.14 | 87.00% |
| Collegium Pharmaceutical Inc | COLL | Drug Manufacturers-Specialty & Generic | 32.5 | 1.05B | 0.68% | 14.45 | 258.31% |
| Alvotech Ordinary Shares | ALVO | Drug Manufacturers-Specialty & Generic | 3.38 | 1.02B | 0.00% | n/a | -196.14% |
| OPKO Health Inc | OPK | Drug Manufacturers-Specialty & Generic | 1.23 | 851.14M | 0.82% | n/a | 19.31% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 9.81 | - | - |
| Ent. to Revenue | 2.09 | - | - |
| PE Ratio | 21.29 | - | - |
| Price to Book | 2.43 | - | - |
| Dividend Yield | 1.38 | - | - |
| Std. Deviation (3M) | 35.56 | - | - |
| Debt to Equity | 0.39 | - | - |
| Debt to Assets | 0.22 | - | - |
| Market Cap | 1.73B | - | - |